Christine Ring Nurix Therapeutics, Inc. (NRIX) insider trading activity

Christine Ring is Chief Legal Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 50,897 shares of NRIX, which is worth approximately $651,481. The most recent transaction as insider was on Dec 18, 2025, when has been sold 3,760 shares (Common Stock) at a price of $18.21 per share, resulting in proceeds of $68,469. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.9K

15.65% 3M change

81.23% 12M change

Total Value Held $651,481

Christine Ring Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2025	SELL Open market or private sale	$68,469 $18.21 p/Share	3,760 Reduced 6.88%	50,897 Common Stock
Dec 18 2025	BUY Exercise of conversion of derivative security	$6,993 $1.86 p/Share	3,760 Added 6.44%	54,657 Common Stock
Nov 24 2025	SELL Open market or private sale	$641,832 $17.07 p/Share	37,600 Reduced 42.49%	50,897 Common Stock
Nov 24 2025	BUY Exercise of conversion of derivative security	$69,936 $1.86 p/Share	37,600 Added 29.82%	88,497 Common Stock
Oct 30 2025	SELL Open market or private sale	$46,643 $12.8 p/Share	3,644 Reduced 6.68%	50,897 Common Stock
Oct 30 2025	BUY Exercise of conversion of derivative security	-	10,532 Added 16.18%	54,541 Common Stock
Jul 30 2025	SELL Open market or private sale	$46,130 $12.01 p/Share	3,841 Reduced 8.03%	44,009 Common Stock

Jul 30 2025	BUY Exercise of conversion of derivative security	-	10,532 Added 18.04%	47,850 Common Stock
Apr 30 2025	SELL Open market or private sale	$33,281 $11.5 p/Share	2,894 Reduced 7.2%	37,318 Common Stock
Apr 30 2025	BUY Exercise of conversion of derivative security	-	7,674 Added 16.03%	40,212 Common Stock
Jan 31 2025	SELL Open market or private sale	$116,409 $20.21 p/Share	5,760 Reduced 15.04%	32,538 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 13.07%	38,298 Common Stock
Jan 30 2025	SELL Open market or private sale	$64,625 $20.07 p/Share	3,220 Reduced 9.0%	32,538 Common Stock
Jan 30 2025	BUY Exercise of conversion of derivative security	-	7,674 Added 17.67%	35,758 Common Stock
Jan 02 2025	SELL Open market or private sale	$112,320 $19.5 p/Share	5,760 Reduced 17.02%	28,084 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 14.54%	33,844 Common Stock
Dec 02 2024	SELL Open market or private sale	$125,164 $21.73 p/Share	5,760 Reduced 17.02%	28,084 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 14.54%	33,844 Common Stock
Nov 04 2024	SELL Open market or private sale	$82,250 $25.0 p/Share	3,290 Reduced 10.49%	28,084 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$31,485 $9.57 p/Share	3,290 Added 9.49%	31,374 Common Stock
Nov 01 2024	SELL Open market or private sale	$139,852 $24.28 p/Share	5,760 Reduced 17.02%	28,084 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$10,713 $1.86 p/Share	5,760 Added 14.54%	33,844 Common Stock
Oct 30 2024	SELL Open market or private sale	$101,622 $24.3 p/Share	4,182 Reduced 12.96%	28,084 Common Stock
Oct 30 2024	BUY Exercise of conversion of derivative security	-	7,674 Added 19.21%	32,266 Common Stock
Oct 14 2024	SELL Open market or private sale	$82,250 $25.0 p/Share	3,290 Reduced 11.8%	24,592 Common Stock

Christine Ring

Chief Legal Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account